Pancrelipase: Clinical Trials

13 trials of Pancrelipase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 active not recruiting, 2 recruiting, 2 terminated. 13 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 213Completed 4, Active not recruiting 2, Recruiting 2, Terminated 2, Unknown 2, Withdrawn 1
Phase 12Active not recruiting 1, Terminated 1
Phase 32Unknown 2

Follow Pancrelipase: new trials by email Literature Review of Pancrelipase trials Research Report on Pancrelipase

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
NHS7108, Zenpep® - Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2RecruitingAimmune Nestlé Health Science US R&D, LLC662026-10-012026-10-01
Phase 2 Study to Assess the Safety and Efficacy of ANG003
ANG003 Dose A, ANG003 Dose B, Creon - Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2RecruitingAnagram Therapeutics, Inc.1132026-04-242026-10-30
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
Pertzye - Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer
Phase 1 / Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center172022-11-302026-02-25
Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children
Pancreatic Enzyme, Ursodeoxycholic acid, Pancreatic Enzyme placebo - SEPSIS, MALNUTRITION, CHILD
Phase 2 / Phase 3UnknownUniversity of Oxford4002021-07-012023-02-24
Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency
Pancrelipase - Pancreatic Adenocarcinoma
Phase 2Active not recruitingAndrew Hendifar, MD362020-12-172026-01-23
Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma
Pancrelipase - Pancreatic Cancer
Phase 2TerminatedDana-Farber Cancer Institute42018-04-132020-08-03
Use of Pancreatic Enzymes in Short Bowel Syndrome
Pancreatic Enzyme - Short Bowel Syndrome
Phase 2CompletedChildren's Hospital of Philadelphia162017-03-242020-03-20
PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer
Pancrelipase, Placebo Oral Capsule - Pancreatic Insufficiency, Pancreatic Cancer
Phase 1 / Phase 2TerminatedMassimo Raimondo, M.D.162016-12-012021-03-15
Fat Malabsorption in Chronic Pancreatitis
Creon36™ - Chronic Pancreatitis
Phase 2CompletedChildren's Hospital of Philadelphia482016-10-132019-05-03
Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis
Pancrelipase, placebo - Pancreatitis
Phase 2WithdrawnDartmouth-Hitchcock Medical Center2016-04-012018-02-27
Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Creon IR, Creon® (DR/GR) - Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis
Phase 2CompletedAbbott702015-03-012016-04-04
Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency
Norzyme - Bergamo, Creon - Pancreatic Insufficiency
Phase 2 / Phase 3UnknownAzidus Brasil252010-03-012010-10-28
An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)
VIOKASE 16 - Exocrine Pancreatic Insufficiency
Phase 2CompletedAxcan Pharma222008-03-012010-02-11

Conditions studied

Exocrine Pancreatic Insufficiency (7)  ·  Pancreatic Neoplasms (3)  ·  Cystic Fibrosis (2)  ·  Child Nutrition Disorders (1)  ·  Dysbiosis (1)  ·  Inflammation (1)  ·  Malnutrition (1)  ·  Pancreatic Diseases (1)  ·  Pancreatitis (1)  ·  Pancreatitis, Chronic (1)  ·  Sepsis (1)  ·  Short Bowel Syndrome (1)

Sponsors

Children's Hospital of Philadelphia (2)  ·  Abbott (1)  ·  Aimmune Nestlé Health Science US R&D, LLC (1)  ·  Anagram Therapeutics, Inc. (1)  ·  Andrew Hendifar, MD (1)  ·  Axcan Pharma (1)  ·  Azidus Brasil (1)  ·  Dana-Farber Cancer Institute (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Massimo Raimondo, M.D. (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  University of Oxford (1)

Countries

United States (10)  ·  Hungary (2)  ·  Poland (2)  ·  Spain (2)  ·  Bangladesh (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Italy (1)  ·  Kenya (1)  ·  Malawi (1)  ·  Uganda (1)  ·  United Kingdom (1)

Top investigators

Andrew Hendifar, MD, MPH (1)  ·  Arthur James Moser, MD (1)  ·  Babette Zemel, PhD (1)  ·  Eileen O'Reilly, MD (1)  ·  James A Berkley, MD (1)  ·  Massimo Raimondo, MD (1)  ·  Monique Bunyan (1)  ·  Natalie Terry, MD, PhD (1)  ·  Phillip P. Toskes, M.D. (1)  ·  Suntje Sander-Struckmeier, PhD (1)  ·  Timothy B Gardner, MD (1)  ·  Virginia Stallings, MD (1)

Results publications

PMID 35622082, PMID 42643234

NIH funding

2014 (1), 2025 (1)